About

Who We Are

AggreDyne is a rapidly growing medical diagnostic company, whose focus is to develop best-in-class medical diagnostic tools that enable physicians and improve the patient experience.

What We Do

The AggreDyne system enhances patient care by producing immediate clinically relevant information, allowing providers to make informed decisions on platelet therapy. The AggreDyne systems are in-vitro diagnostic tests that measure platelet dysfunction and how well the patient is responding to antiplatelet therapy.
Patient response to antiplatelet agents varies, and poor response may be associated with increased risk of ischemic events. Monitoring antiplatelet therapy with PFT allows providers to treat patients with the safest therapy that provides the desired effect.

 

 

 

Our Team

 

 

ROBERT C. HUX

President/CEO

Mr. Hux has extensive experience in finance, especially as a turnaround specialist. Early in his career, he was an auditor at Ernst & Young. He was the founding CEO and Director for HEI Corp., a public company that began with two hospitals in bankruptcy that he turned around, grew to six hospitals, and sold to what is now HCA. He has also led turnarounds in the transportation and medical publishing business, and has started-up an oil and gas machining business along with numerous other start-ups including Blockbuster Video, which he and others later sold to Viacom. He has served as a court appointed trustee for multiple Cullen Trusts for twenty years.


Midiam Stubblefield

Product Specialist

WILL UPDATE SOON


Eddie Allen

Laboratory Supervisor

WILL UPDATE SOON


Faith Benjamin

Quality Engineer

Faith Benjamin is an experienced engineer with over 20 years in diagnostic medicine and total quality management. Her clinical diagnostic expertise is in the field of Hematology and Coagulation. She leverages proficiencies in CAP, ISO and JCAHO accrediting bodies as well as CLIA and FDA regulatory mandates.
Her deep knowledge of clinical diagnostic medicine and 17 plus years as a Senior Scientist in the field of Hematology and Coagulation contributes greatly to AggreDyne’s product line development, market reach, and Quality Management System.
She received a Master of Science in Industrial Engineering from Saint Mary’s University in San Antonio, Texas while working in diagnostic medicine. For her thesis, she developed two algorithms that solved problems in Cancer Treatment and Care. She is also a graduate of the University of Texas with a Bachelor of Science in Clinical Laboratory Science.


Johnny Rhodes

Senior Engineer

Johnny Rhodes has a bachelor’s degree from the University of Utah in Biomedical Engineering with a minor in Computer Science. During his studies, he worked as a research assistant at the Utah Artificial Heart Institute (UAHI) in Salt Lake City doing in-vivo testing of left ventricular assist devices (LVADs). After graduation in 2003 he began work as an R&D engineer for Thrombodyne, a startup company that was teaming up with UAHI to develop a Platelet Function Analyzer that is now Aggredyne’s A-100 Platelet Function Testing Instrument. Johnny designed the electro-optics module, disposable assay cartridge, enclosure, computer/touchscreen configuration, custom Windows environment, and the LabVIEW program that runs the assay. In 2008 Johnny moved with his family to Houston to further develop the A-100 platelet analyzer. From 2010 until 2012 Johnny was a Manufacturing Systems Engineer at MicroMed Cardiovascular developing a new controller for an LVAD. In 2012 Johnny joined the Aggredyne team.


Jim Bourgeois

Business Development and Project Manager

Jim Bourgeois joined Aggredyne in 2020 with over 20+ years directing business, managing projects, marketing, and IT solutions providing business intelligence solutions for clientele. He graduated from the University of Texas with a Bachelor of Business Administration. Post-undergraduate work in the Master of Science program at St. Mary’s University.


Richard Fisher

Senior Medical Advisor

Dr. Fisher is a Distinguished Professor Emeritus of Baylor College of Medicine. Dr. Fisher received his medical training (degrees) primarily at the University of Texas Medical Branch in Galveston, Texas in 1963. He is a Board-Certified Radiologist as well as CAQ certified in Vascular and Interventional Radiology (ACR). Dr. Fisher is extensively published in Interventional Radiology.
Dr. Fisher has been involved with Aggredyne since its inception (2011) as the Senior Medical Advisor and subsequently as Medical Director since 2015.


Board of Directors

 

 

BRADY F. CARRUTH,

CHAIRMAN

Brady Carruth has extensive business experience in acquiring and operating several distribution and service businesses in the Houston area. He has served on the boards of directors of two NYSE-listed companies, including American General Corp. until its merger with American Intl. Group in August 2001.

Mr. Carruth, a native Houstonian, earned his MBA with a concentration in finance and insurance from the University of Texas at Austin. Active in several Houston-community civic and cultural endeavors, he serves as president of the Wortham Foundation, one of Houston’s largest philanthropic institutions.

In 2002, he acquired London American Risk Specialists, Inc. IMS Insurance Market Solutions acquired London American in 2010, creating IMS/London American, one of the largest independent multi-line managing general agencies in the Southwest. Mr. Carruth continues as a director and equity participant.


EDGAR C. “RED” GRIFFIN

Red Griffin turned his early work as an oilfield roughneck and commercial power salesman (plus studies at the University of Texas and the University of Houston leading to a marketing degree) into a career in entrepreneurship.

He started as an independent broker of barges and towboats, and then formed Coastal Towing as president and chairman of the board. Mr. Griffin grew Coastal from six tank barges and three towboats to 136 tank barges and 36 towboats. When he sold the company in 2001, Coastal Towing was the largest transporter by barge of heavy liquid fuel oil on the inland waterways of the United States.

In 2001, Mr. Griffin formed Grifco Transportation, Ltd. He built the company in less than eight years to 20 tank barges and 10 towboats. He sold Grifco in 2008 for $125 million to Genesis Energy Partners, a NYSE-traded company.

Meanwhile, he served on the boards of directors of two banks. He is a lifetime vice president and director of the Houston Livestock Show and Rodeo, where he continues to be active. Additionally, he has served, and continues to serve, on the boards of several local charities.


ROBERT C. HUX

Mr. Hux has extensive experience in finance, especially as a turnaround specialist. Early in his career, he was an auditor at Ernst & Young. He was the founding CEO and Director for HEI Corp., a public company that began with two hospitals in bankruptcy that he turned around, grew to six hospitals, and sold to what is now HCA. He has also led turnarounds in the transportation and medical publishing business, and has started-up an oil and gas machining business along with numerous other start-ups including Blockbuster Video, which he and others later sold to Viacom. He has served as a court appointed trustee for multiple Cullen Trusts for twenty years.


SARA OSTROFSKY

Sara Ostrofsky graduated from the University of Texas in Austin. Since then she has been active in the publishing of various trade publication in the telecommunications in-dustry. She has also been involved with the deregulation of the pay telephone, pre-paid phone cards and the start of voice technology. She is an owner/investor/mentor in many startup companies in the beauty and movie industries. Ms. Ostrofsky is also active and several charities in the Houston community.


DENNIS STEGER

Dennis Steger is the founder of three major shipyard facilities, and a medical clinic in the Houston area. He served as the Chairman for the Shipyard Council of America from 1996-1997. He had also served as the Chairman and Director of Lone Star Bank from 1992 – 1998, and was a catalyst in its merger with Sterling Bank in 1998. Mr. Steger graduated from Murray State University in Kentucky. He has always been an active participant in the Houston community. He has been a Director of the Houston Livestock Show & Rodeo since 2004, and a Vice President since 2013. He has served as a Director for the City of La Porte Water Authority since 2004, and is a member of the 20 Year Planning committee for the City of La Porte.


SIVAPRASAD SUKAVANESVAR, PHD

Dr. Sukavaneshvar has deep expertise in the fields of platelet/thrombosis/hemocompatibility. His experience is supplemented with an engineering background and device design experience. He is extensively published and is well recognized in his field. He was instrumental in developing the AggreGuide technology and brings extensive critical knowledge of the AggreGuide’s nuances to the Company. He will advise and guide AggreDyne’s technological development program while maintaining his full time position as a Vice President of Thrombodyne.


 

Press Release

 

Aggredyne receives FDA clearance for the AggreGuide A-100 Liquid Quality Control (LQC) Kit. The CLIA regulation, section 493.1256 under Control Procedures, specifies that the laboratory must perform control procedures as specified by the test manufacturer.  Our AggreGuide A-100 LQC Kit is used without blood and permits the User to verify the correct operation of the AggreGuide A-100 ADP Assay cartridges in the AggreGuide A-100.

 

Industry Information

Platelets play an important role in thrombosis and hemostasis. Understanding and modulating their reactivity is central to the management of patients with certain pathologies.

 

Importance of Platelet Function Testing with AggreGuide A-100 amid the COVID-19 Outbreak.
error: